Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stem cell bioengineered skin

This article was originally published in The Gray Sheet

Executive Summary

U.S. BioDefense, Inc. files for Small Business Innovation Research Grant to support development of its stem-cell technology for the creation of skin grafts to treat skin wounds. The company is focused on the treatment of vesicant-agent-induced cutaneous burns that would result from a mustard gas or other biological weapon attack. The City of Industry, Calif.-based firm is taking advantage of California Proposition 71, which approved an unprecedented $3 bil. investment in stem-cell research funding over the next decade. Wisconsin also is looking to fund stem cell research (1"The Gray Sheet" Nov. 29, 2004, p. 13)...

You may also be interested in...



Wisconsin R&D Windfall Bids To Make Entrepreneurs Of Academics

Medical technology researchers on the University of Wisconsin-Madison faculty will be encouraged to commercialize their findings under a state government initiative costing roughly $750 mil

California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits

The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.

Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer

Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025.  It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021503

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel